Cartalax
Also known as: Ala-Glu-Asp, AED Tripeptide, T-31
Primary recreational use: Joint health and longevity support
What is Cartalax?
Cartalax is a synthetic tripeptide bioregulator developed by Professor Vladimir Khavinson. It is primarily used for supporting cartilage and connective tissue health, particularly in joint regeneration and cellular repair. While available in Russia, it is not FDA approved and primarily studied in preclinical settings. Users should be aware of limited human research and potential risks associated with non-regulated use.
Primary Benefits
Supports cartilage regeneration. Enhances joint function. Promotes cellular renewal.
How It Works
Cartalax influences gene expression in chondrocytes and cartilage tissue, promoting the synthesis of matrix proteins like collagen and glycosaminoglycan. This bioregulatory effect may enhance joint health and support regenerative processes by modulating proliferation markers and apoptosis pathways.
Safety Tips
Precautions reported in community discussions and literature. This is not a complete list.
- 1.DON'T start with high doses; begin with small amounts to assess tolerance.
- 2.NEVER chew or open capsules; swallow whole with water.
- 3.AVOID use if you have a known collagen disorder.
- 4.DON'T store in moist environments; keep in a dry place.
- 5.NEVER use Cartalax as a substitute for prescribed joint treatments.
Use Contexts
Different purposes have different protocols, dosing, and considerations
Joint Health and Recovery
limited evidenceCartalax is used in research settings to explore its effects on joint regeneration, cartilage health, and recovery from joint injuries.
Evidence: Primarily studied in preclinical lab models with focus on cartilage repair and joint function enhancement.
The following are ranges reported in published literature and community discussions. These are NOT recommendations or medical advice.
Timing: With meals to enhance absorption
Notes: Initial loading phases may require higher dosing; adjust based on response
Community-Reported Protocols
Not recommendations: The following protocols are compiled from online communities and published literature. Pepbase does not endorse, recommend, or verify these protocols. They are provided for informational purposes only. Individual responses vary significantly. Consult a licensed medical professional before any use.
| Reported Goal | Reported Dose | Reported Frequency | Reported Route |
|---|---|---|---|
| Joint Health | 1-2 capsules (100-200mcg) | 1-2 times daily with meals | Oral |
Pharmacokinetics
Reported Side Effects
This is not a complete list. Other side effects may occur.
Common
Storage
Harm Reduction Information
Quality Concerns
- Potential contamination if sourced from unregulated suppliers
- Variability in active peptide concentration
- Improper storage leading to degradation
Safety Tips
- Use sterile technique if using in a lab setting
- Rotate injection sites if applicable
Warning Signs to Stop
- Severe gastrointestinal discomfort
- Unexplained joint pain
Seek Medical Help Immediately If
- Severe allergic reaction symptoms such as hives or swelling
- Indications of infection at injection site
Frequently Asked Questions
Common questions about Cartalax
How long until I see effects?
With Cartalax, some users report joint improvements within 3-4 weeks, with full benefits often taking 2-3 months.
What time of day should I take it?
Cartalax should be taken with meals for optimal absorption and to minimize gastrointestinal discomfort.
How can I minimize side effects?
Taking Cartalax with meals is recommended to optimize tolerance and minimize gastrointestinal issues.
Does tolerance develop?
There is no strong evidence to suggest that tolerance to Cartalax develops over time; cycling may still be beneficial.
How should I store it?
Store Cartalax at room temperature in a dry place away from moisture.
Do I need to cycle it?
Cycling Cartalax is recommended, with typical cycles lasting 1-3 months followed by a break of 3-6 months.
Can I combine it with other peptides?
Cartalax can be combined with peptides like BPC-157 and TB-500 for synergistic effects on joint health.
Reported Combinations
Compounds reported to be used alongside Cartalax in community discussions
BPC-157
Potential synergistic effect on joint repair and inflammation reduction.
TB-500
May enhance regenerative processes in connective tissues.
Collagen Supplements
Supports cartilage health alongside Cartalax administration.
Reported Interactions
Interactions reported in literature and community discussions.
May increase GI side effects
Possible synergistic effect on joint health
No known adverse interactions
May interfere with capsule absorption
Can be synergistically beneficial for cartilage health
Reconstitution Calculator
100 units = 1 mL
Safety Tips
- Always consult a licensed medical professional for dosing and reconstitution instructions.
- Always double check your units. Mixing up mg and mcg can be very dangerous.
- Make sure to select your syringe type. U-100 and U-50 syringes have different units.
- Ensure you're not adding more BAC than your vial can hold. Most vials have maximum capacities listed.
This calculator is for informational and educational purposes only. It does not provide medical advice, dosing recommendations, or safety determinations. Reference ranges shown are compiled from publicly available sources and are not a substitute for guidance from a licensed healthcare professional.
Legal Status by Region
Regulatory status varies by country
USA
Not Approved for Human Use
UK
Not Approved for Human Use
EU
Not Approved for Human Use
Australia
Not Approved for Human Use
Canada
Not Approved for Human Use
Explore More Research
Browse our database of peptide research information compiled from published literature and community sources.
Citations
Last updated: October 1, 2023